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ABSTRACT
￿
Galactosylated BSA (gaIBSA) and its conjugate to horseradish peroxidase (gaIBSA-
HRP) enter the galactose-specific pathway of hepatocytes. 10 min after intravenous injection,
structures containing either ligand sediment mostly between 33,000 and 3 x 106 g~min (LP
fraction) and have an equilibrium density of 1 .11-1.13 g/ml in sucrose gradients (Quintart, J.,
P. J . Courtoy, J . N . Limet, and P. Baudhuin, 1983, Eur. J. Biochem., 131 :105-112).
Such low density fractions, prepared from rats given gaIBSA-HRP, were incubated for 30
min at 25°C in 5.5 mM 3,3'-diaminobenzidine (DAB) and 11 mM H202 in buffered sucrose.
Upon equilibration in a second sucrose gradient, the gaIBSA-HRP distribution shifted towards
higher 01 .19 g/ml) density, but the bulk of protein remained at low density. In the absence
of H202, gaIBSA-HRP distribution was also found at low density . As observed by electron
microscopy, particles equilibrating at higher density after DAB cytochemistry were largely
made of vesicles or tubules filled with DAB reaction product. The density shift of gaIBSA-
HRP-containing organelles after incubation with DAB and H zOz is attributed to the trapping
of HRP-oxidized DAB inside the host organelles.
If the low density fractions isolated from a rat injected with [3 H]gaIBSA-HRP were mixed in
vitro with similar fractions from another rat given [' 4C]gaIBSA, the 3 H distribution shifted after
DAB cytochemistry, but the '4C distribution was essentially unaffected. By contrast, if both
derivatives were injected simultaneously, a concomitant density shift was observed .
In conclusion, the DAB-induced density shift was specific to ligand-HRP-containing organ-
elles . The potentials of the method include the purification of HRP-containing particles and
the study of their association to ligands, fluid-phase tracers, or marker enzymes.
After receptor-mediated internalization (3, 28), ligands are
rapidly transferred to an "intermediate compartment" (34,
37), often referred to as "endosomes" (14) or "receptosomes"
(37). To assess the purity of subcellular fractions enriched in
ligand-containing organelles, we recently used ligands conju-
gated to horseradish peroxidase (HRP),' an approach that
proved successful in intact liver (29, 33). Glutaraldehyde-
fixed fractions were incubated in 3,3'-diaminobenzidine
' Abbreviations used in this paper:
￿
DAB, 3,3'-diaminobenzidine;
gaIBSA, galactosylated BSA; gaIBSA-HRP, gaIBSA conjugated to
horseradish peroxidase(HRP).
(DAB) and HZOz (12) and processed for electron microscopy.
The organelles containing ligand-HRP were identified by the
DAB reaction product (23). We report here that the DAB
procedure can also be applied to unfixed subcellular fractions.
Moreover, the accumulation of polymerized DAB inside
HRP-containing organelles induces a major increase in their
equilibrium density, while other organelles of the same frac-
tion are essentially unaftècted.
It has already been reported that cytochemical procedures
may be applied to the isolation of specific organelles with
endogenous marker enzymes, such as glucose 6-phosphatase
(19) and 5'-nucleotidase (25) using lead cytochemistry, or
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In comparison, the DAB-induced density shift takes advan-
tage of a highly sensitive, exogenous enzyme, that can be
introduced into specific organelles along the endocytic path-
way by fluid-phase or receptor-mediated endocytosis (7, 23,
27, 29, 33). In addition, this procedure is simple, fairly repro-
ducible, and proved useful to analyze and to purify ligand-
HRP-containing organelles (24). This work has already been
presented in abstract form (5).
MATERIALS AND METHODS
Preparation of Ligand and Ligand-HRP Conjugates: Ga-
lactosylated BSA (gaIBSA) was prepared according to Wilson (38), using a 96-
h incubation in a 0.1 M borate buffer at pH 9. It was radiolabeled by reductive
methylation (21), using ["C]formaldehyde (The Radiochemical Centre, Amer-
sham Corp., UK). Unlabeled gaIBSA was conjugated to HRP (type VI, Sigma
Chemical Co., St. Louis, MO) after Nakane and Kawaoi (22) and labeled with
sodium ['H]borohydride (Amersham Corp.). The conjugate (gaIBSA-HRP) was
cleared of unconjugated HRP and gal BSA, as well as of large polymer; or
aggregates, by isokinetic centrifugation in a sucrose gradient (17).
Characterization of Ligand-HRP Conjugates: The HRP/
gaIBSA molar ratio, determined from the absorbance at 280 and 403 nm, was
1.4 and l.7 for the two preparations used in this study. Ligand concentration
was measured afterLowry et al. (20), using BSA as standard. The HRP activity
ofthe conjugate was assayed using N,N-dimethyl-p-phenylenediamine (Merck,
Darmstadt, Federal Republic ofGermany) according to Straus (30) or DAB in
a gelatin medium, as described by Herzog and Fahimi (16). This activity
corresponded to 240-400 Wg HRP (type VI)/mg gaIBSA. Radioactivity was
measured in a Beckman LS 7500 DPM liquid scintillation counter (Beckman
Instruments, Palo Alto, CA), afterdissolution ofthe sample in 10 ml Aqualuma
cocktail (Lumac Systems, Basel, Switzerland).
Ga1BSA-HRP conjugate, like gaIBSA, was recognized almost exclusively by
the galactose-specific receptor of the hepatocytes since: (a) after intravenous
injection to rats, the conjugate was rapidly cleared from the blood by the liver,
(b) after cytothemistry, gaIBSA-HRP was found almost exclusively in the
hepatocytes by light and electron microscopy, and (c) the uptake ofga1BSA-
HRP by cultured rat hepatocytes could be inhibited by a large excess of
asialofetuin or gaIBSA, but not by native BSA. In addition, the subcellular
distribution ofboth ligands after dif%rential and isopycnic centrifugations was
comparable, indicating similar processing by the cell (23).
Preparation ofDAB Solutions:
￿
3,3'-Diaminobenzidinetetrahydro-
chloride (type II, lot 88C-03201, Sigma Chemical Co.) was dissolved at a
concentration of 2.56 mg/ml (7.1 mM) in 0.74 M sucrose (density: 1.1 g/ml),
buffered with 3 mM imidazole/HCl (31) and the pH was carefully adjusted to
7.0 with concentrated NaOH. This brownish solution was cleared by filtration
on two layers ofa 0.2-gym pore MetricelA filter (Gelman, Ann Arbor, MI) and
used extemporaneously. The absorbance at 280 nm ofthe filtrate diluted 50 .
fold was 1 .63 t 0.06. The stability of DAB solutions in the presence ofHzOz
was routinely checked before use. Solutions that rapidly turned brown were
discarded.
Subcellular Fractionation:
￿
Rats (200-25o g) were injected intrave-
nously with I kg/g body wt fH]gaIBSA-HRP (126 nCi/wg) or ["C]gaIBSA (7
nCi/pg). 10 min after injection, the liver was perfused by the portal vein with
H l6 tissue culturemedium (Gibco Biocult, Paisley, UK). The liverhomogenate
was fractionated by dif%rential centrifugation (9) to successively pellet N
(10,000 g~min), M (33,000 g~min), and combined LP (3 x 106 g~min)
fractions.z LP fractions (Sml) were layered on the top ofa 32-m1 linear sucrose
gradient (from 1 .1 to 1.3 g/ml in density), buffered with 3 mM imidazole/HCI,
pH 7.0. After centrifugation for 24 x 106 g~min in a VTi 50 rotor (Beckman
Instruments), l4 fractions were collected and analyzed as previously described
(23). The two fractions containing the highest radioactivity (average density:
I .12 g/ml) were pooled and will be further referred to as LP, pool.
Forthe diaminobenzidine procedure, 1.75 ml ofthe LP, pool was added to
6.25 ml of the DAB solution (final concentration: 5.5 mM, nominal). The
reaction was started by the addition of 50 ~1 of 6% HZOz, prepared extempo-
raneously by dilution ofa 30% H20z stock solution in sucrose-imidazole, and
performed for 30 min at 25°C, in the dark, under gentle agitation. The H,Oz
concentration in theincubation medium (l I mM)was measuredbytheTiOSOe
z See Materials and Methods of the companion paper (24) for an
explanation of the fraction nomenclature.
colorimetric assay (4). The stock HZOz concentration was verified by KMnO,
titration (32).
After incubation, 5 ml ofthe suspension was equilibrated in a second linear
sucrose gradient (density, 1.13-1.30 g/ml). Fractions therefrom were analyzed
for density, radioactivity, and enzyme activities. Owing to an interference of
DAB with the protein assay of Lowry et al. (20), liver protein was labeled in
some experiments by a pulse of['°C]leucine (125 ~Ci) injected intraperitoneally
40 h before sacrifice. In such conditions, values of 3.6 ± 0.7 nCi/mg liver
protein and 431 ± 3 nCi/mlplasma were obtained (n = 3).
EIeCtron MiCrOSCOpy:
￿
The subcellular fractions were fixed by the
slow addition ofglutaraldehyde (7.5% in 0.1 M cacodylate, pH 7.4) to a final
concentration of 1 .5% ( l8) and kept overnight at 4°C. About 100 ~g ofprotein
of each fraction ofinterest was then applied over a I-cmz MilliporeR filter, 50-
nm nominal pore size (Millipore Corp., Bedford, MA), and filtered under one
to two bars (2). The retention of the material on the filter was ascertained by
measuring the radioactivity of the filtrate and was >90%. The pellicle was
post6xed for I h at 4°C in a solution containing 1 % osmium tetroxide and l
potassium ferrocyanide and dehydraded in graded alcohol. After dissolution of
the nitrocellulose filter in propylene oxide, the pellicle was embedded in the
mixture described by Spurr (26). Ultrathin sections were examined unstained
under 60 kV in a EM 301 Philips electron microscope.
RESULTS
Effect of DAB Cytochemistry on the Density
Distribution of gaIBSA-HRP
The density distributions of ['H]gaIBSA-HRP- or ['4C]-
ga1BSA-containing organelles, sedimenting in a LP fraction,
are illustrated at Fig. l. 10 min after intravenous injection,
both ligands are associated to structures that equilibrate in
the low density region of the sucrose gradient and that are
dissociated from the bulk ofprotein (23). For DAB cytochem-
istry, the LP, pool corresponding to the peak of the [3H]-
ga1BSA-HRP distribution (density, 1.11-1 .13 g/ml) was in-
cubated at 25°C in buffered sucrose (density, 1 .1 g/ml), con-
taining 5.5 mM DAB and 11 mM HZOz. This resulted in the
development ofa brownish color. In the absence of HZOZ, the
mixture remained yellowish. After 30 min incubation, the
granules were equilibrated again in a sucrose gradient.
IfHZOz was included in the incubation medium, the density
distribution of [3H]ga1BSA-HRP shifted towards a heavier
density, upon equilibration in a second sucrose gradient (Fig.
2). The increment in median equilibrium density was 0.054
g/ml (SD: 0.004, n = 4). By contrast, the bulk of ['°C]leucine-
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FIGURE 1
￿
Density dis-
tributions of ['H]gal-
BSA-HRP or ['°C]gal-
BSA. ['H]gaIBSA-HRP
or ['`C]gaIBSA were in-
jected intravenously (1
Wg/g body wt of either
ligand) into rats, 10 min
before sacrifice. LP
fractions were pre-
pared and layered on
top of a sucrose gra-
dient. Protein was de-
termined by the proce-
dure of Lowry et al.
(20). Distributions arè
averages of seven ex-
periments. Recoveries
were 108.4, 119.7, and
98.5% of the LP frac-
tion for ['H]gaIBSA-
HRP, ['`C]gaIBSA, and
protein, respectively.
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FIGURE 2 Density distribution of [3H]gaIBSA-HRP after DAB cy-
tochemistry. Rats were given a pulse of ['°C]leucine 40 h before
sacrifice, so as to label liver protein. ['H]gaIBSA-HRP was injected
intravenously (1 kg/g body wt), and the liver was homogenized 10
min thereafter. An LP fraction was layered over a sucrose gradient
and centrifuged . The fractions equilibrating between 1 .11 and 1 .13
g/ml in density were pooled (LP, pool), incubated for 30 min in 5.5
mM DAB in the presence or absence of 11 mM HZO2, and equili-
brated again in a sucrose gradient (mean values of two experiments).
Average recoveries with respect to the LP, pool were 95.8% for
[3H]gaIBSA-HRP and 105.0% for [' ^C]leucine.
labeled protein remained in the low density region, although
a minor component shifted towards a heavier density, prob-
ably representing protein associated with ligand-containing
structures. If HzOz was omitted, the distributions of [3H]-
ga1BSA-HRP- and ['°C]leucine-labeled protein remained at
low density. In this case, distributions were only slightly
shifted 00.01 g/ml in density) in comparison to fractions
incubated without DAB.
Origin and Factors of the DAB-induced
If ga1BSA-HRP was replaced by ga1BSA, or if either DAB
or Hz02 was omitted from the incubation medium, no sig-
nificant change in the color or the distribution of the ligand
was observed. Therefore, the major shift of the equilibrium
density of ligand-HRP conjugates after incubation in DAB
and HZOz stems from the oxidation of DAB by HRP. These
experiments also indicate that no significant endogenous
HZOZ or peroxidatic activity was present in the low density
fractions.
The relation between the association of oxidized-polymer-
ized DAB to the granules and the density shift was further
studied. First, the density distribution of oxidized DAB after
cytochemistry was compared with that of gaIBSA-HRP. For
this purpose, LP, pools were prepared from rats injected with
either gaIBSA-HRP or ga1BSA. After incubation in presence
of DAB and HzOs, the preparations were equilibrated in a
O/ 2
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second sucrose gradient and the absorbance at 465 nm was
measured. The difference in the absorbance of corresponding
fractions was taken as an estimate of HRP-oxidized DAB. As
can be seen in Fig. 3, the distributions of oxidized DAB and
gaIBSA-HRP were very similar. Next, DAB was oxidized and
polymerized with ferricyanide (13) or by soluble HRP and
HZOZ and then layered on the top of a sucrose gradient. After
centrifugation, all brown material was found as a pellet below
the heavy sucrose cushion (density, 1 .34 g/ml). This demon-
strates that the equilibrium density of oxidized and polymer-
ized DAB is > 1.34 g/ml and that accumulation of this com-
pound inside vesicles should result in a substantial increase
oftheir equilibrium density.
Changing parameters of the DAB reaction was shown to
influence the extent of the density shift. Reduction of the
amount of ga1BSA-HRP injected, of incubation time, or of
DAB concentration all resulted in a smaller density shift of
the ga1BSA-HRP distribution (Fig. 4). In our standard con-
ditions (5 .5 mM DAB), the DAB concentration was not
largely decreased at the end of the incubation, as measured
by performing the gelatin assay (16) in the presence of a
constant HRP concentration. In the same conditions, HZOz
concentration rapidly dropped, with a half-life of ~ 10 min.
However, repeated addition of HzOz during the incubation
did not enhance the density shift. We also tested if the one-
step addition of HZOz could be replaced to advantage by a
continuous production of HzOz, using a glucose/glucose oxi-
dase system. A similar DAB-induced density shift could be
produced but the procedure was less reproducible.
Finally, to assess the accessibility of DAB into membrane-
closed organelles, LP, pools from rats injected with gaIBSA-
HRP were assayed for HRP activity, in a medium containing
0.74 M sucrose, 3 mM imidazole/HCI, pH 7.0, 5.5 mM DAB,
11 mM HZOz, and 0.1 % gelatin, in the presence or absence
of 0.1 % Triton X-100. While Triton X-100 had no significant
effect on the activity offree HRP, its addition to the organelle
suspension caused a 10-fold increase of the HRP activity. In
our opinion, these observations most likely reflect a restriction
in the diffusion of soluble DAB through intact biological
membranes, although an inhibition of HRP by the reaction
product trapped inside the particles could also explain our
results.
Specificity of the DAB-induced Density Shift
To assess the specificity ofthe density shift, in vitro mixing
experiments were performed. A rat was injected with ['H]-
ga1BSA-HRP and another one received ['°C]ga1BSA. LP,
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FIGURE 3 Distribution
of oxidized DAB after
density equilibration.
LP, pools were pre-
pared from rats in-
jected with either [3H]
gaIBSA-HRP or ['°C]-
gaIBSA. After incuba-
tion in DAB and HZO~,
they were equilibrated
again in a sucrose gra-
dient. The distribution
of HRP-oxidized DAB
was estimated from the
absorbance at 465 nm
(see text).ô~
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￿
In vitro mix-
ing experiment. LP,
pools were prepared
from rats given ei-
ther ['H]gaIBSA-HRP
or ['^C]gaIBSA 10 min
before sacrifice and in-
cubated in DAB and
HZOz, separately (A and
B) or together (C). Av-
erage recoveries with
respect to the LP, pool
were 97.5% for ['H]-
gaIBSA-HRP and 97.0%
for ['°C]gaIBSA.
pools were isolated as previously described. First, they were
incubated separately in DAB and HZOz and equilibrated again
in a sucrose gradient. As in the previous experiments, the
distribution of gaIBSA-HRP was shifted to a higher density
and that of gaIBSA was not appreciably affected. Next, the
LP, pools from the two animals were mixed in vitro, incu-
bated together in DAB and HZOz, and equilibrated again in a
sucrose gradient. The distribution of [3H]gaIBSA-HRP was
shifted and that of ['°C]gaIBSA remained essentially un-
changed (Fig. 5). This demonstrates that the DAB-induced
density shiftis specific to HRP-containing organelles and that
no appreciable agglutination, or fusion between similar organ-
elles, occurred in our experimental conditions. Therefore, the
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FicuRE 4 Kinetics and param-
eters of the DAB-induced den-
sity shift. Same preparations as
in Fig. 2 . The ordinate is the dif-
ference in the median equilib-
rium density of ['H]gaIBSA-HRP
after incubation in DAB with and
without HZOz. (A) Effect of the
amount of gaIBSA-HRP. The pla-
teau reached at 10 ng/mg of liver
protein corresponds to the injec-
tion of 250 ng/g body wt. (B)
Effect of incubation time. DAB
concentrations used are 1 .4 mM
(open circles), and 5.5 mM
(closed circles). (C) Effect of DAB
concentration.
FIGURE 6
￿
In vivo mix-
ing experiment. A rat
received a simultane-
ous injection of ['H]
gaIBSA-HRP and ['°C]-
gaIBSA (0.5 wg/g body
wt of each derivative),
10 min before sacrifice.
(A) An LP fraction was
equilibrated in a su-
crose gradient; (B) the
LP, pool isolated from
A was incubated in the
presence of DAB and
HZOz for 30 min, and
equilibrated again in a
sucrose gradient. Aver-
age recoveries were
101 .5% for [;H]gaIBSA-
HRP and 103.5% for
['"C]gaIBSA, with re-
spect to the sample lay-
ered on the gradient.
DAB-induced density shift can be used to demonstrate the
dissociation of two similar and yet distinct subcellular popu-
lations.
By contrast, if free HRP (1 wg/ml) was added to the LP,
pool from a rat injected with gaIBSA and incubated with DAB
and HzOz, DAB was immediately oxidized and the radioac-
tivity was recovered with DAB as a pellet, below a density of
1 .34 g/ml. This indicates that free HRP caused the aggluti-
nation ofparticles and that the specificity ofthe DAB-induced
density shift may be jeopardized in the presence of soluble
HRP and possibly of other heme proteins.
Concomitant Density Shift of Two Ligands
A rat received a simultaneous injection of [3H]ga1BSA-
HRP and ['4C]ga1BSA. An LP fraction was first equilibrated
in a sucrose gradient. The density distribution ofboth ligands
was similar and displayed a peak in the low density region.
The LP, pool was incubated in DAB and HZOz and equili-
brated again in a sucrose gradient. The density distributions
of gaIBSA-HRP and gaIBSA shifted concomitantly (Fig. 6).
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Ultrastructural demonstration of HRP-containing organelles after DAB-induced density shift . Unfixed LP, pools were
incubated in DAB and H zO z and equilibrated again in sucrose gradients, as described in Fig . 2 . Fractions enriched in f H]gaIBSA-
HRP-containing organelles were recovered at high density after the DAB-induced density shift . The 1 .23-g/ml fraction was fixed,
filtered on MilliporeR, and processed for electron microscopy without further incubation in DAB and H zOZ . Ullmlhin sections,
perpendicular to the filter surface, were usually examined unstained . The field shown in a is a general view of the pellicle (filter
is at bottom) . Notice the abundance and heterogeneity of the organelles filled with DAB reaction product. Enlargements (b-f)
illustrate various aspects of isolated ligand-containing structures . They include sections through small and large vesicles (b), often
containing numerous small (10-20 nm) electron-lucent spheres (c), cupshaped vesicles (d), and elongated or tortuous tubules (e)
frequently connected to small (d) and large profiles (f) . Contaminants, which are identified in stained sections (inset to a), are
largely made of endoplasmic reticulum elements . (a) x 44,000 ; inset : x 44,000, (b, c, and f) x 75,000 ; (d) x 58,000; (e) x 71,000 .
Other structures remained essentially at the initial low density,
as indicated by the distributions of marker enzymes for the
plasma membrane, lysosomes, and the Golgi complex (not
shown) . The density distributions of these marker enzymes
are presented in detail in the companion paper (24).
Since the density shift induced by ga1BSA-HRP ("active"
ligand) caused a concomitant density shift of ga1BSA ("pas-
sive" ligand), but not of other components, this experiment
demonstrated that both derivatives were localized within the
874
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same organelles. This result illustrates that the DAB shift
procedure could be used to test directly whether components
with overlapping distributions in a fractionation system are
truly associated to the same host particles, provided aggluti-
nation of granules can be excluded (see Discussion).
Electron Microscopy
After the DAB-induced density shift, the material recovered
at the density of 1 .23 g/ml was fixed, processed for electron~r ~j
DAB, H202 ~ 0
+ +
￿
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FIGURE 8
￿
Model forthe DAB-induced density shift. In theabsence
of HRP or HZOZ, DAB diffuses slowly in and out all organelles. In
those vesicles that contain HRP, DAB is oxidized and polymerized
in thepresence of H202 and remains trapped. Sincethe equilibrium
density of polymerized DAB is high (>1.34 g/ml), this results in a
large, specific increase in the equilibrium density of HRP-containing
vesicles.
microscopy without further incubation in DAB and HzOZ,
and examined unstained (Fig. 7). For comparison, LP, pools
were first fixed and then incubated in DAB and HZOz. In
both preparations, ligand-containing structures were identi-
fied as vesicles and tubules filled with electron dense material.
However, application of the cytochemical procedure of Gra-
ham and Karnovsky (12) to unfixed organelles resulted in a
lower contrast than with fixed specimens (see Fig. 7 of refer-
ence 23 for comparison). This is attributed to the restricted
diffusion of soluble DAB through intact membranes, as pre-
viously discussed. Whereas DAB-stained structures repre-
sented a small proportion of the organelles occurring in the
LP, pool (not shown), they constituted a major component
(45-53% of the total volume of particles) of the high density
fractions, afterthe DAB-induced density shift.
DISCUSSION
Physical Basis of the Density Shift
Several lines of evidence indicate that the shift in the
equilibrium density of HRP-containing organelles results
from the trapping ofDAB that has been oxidized and polym-
erized inside these organelles by HRP: (a) the density shift
requires the simultaneous presence ofHRP, DAB, and HzOz,
and increases as a function of HRP and DAB concentrations;
(b) the density distribution of ligand-HRP conjugate after
cytochemistry was similar to that of HRP-oxidized DAB; (c)
as observed by electron microscopy, a large proportion ofthe
structures equilibrating at higher density after cytochemistry
were filled with DAB reaction product; and (d) the equilib-
rium density of polymerized DAB is > 1 .34 g/ml.
Ourinterpretation ofthe physical basis ofthe DAB-induced
density shift is outlined in Fig. 8. The model accounts for the
major increase in density of HRP-containing organelles, and
for the specificity of the density shift, which is restricted to
HRP-containing structures. Although our results imply that
DAB gains access inside unfixed closed structures, the latency
ofHRP towards DAB in preparations ofintact granules points
to a restriction of the diffusion of DAB through biological
membranes. This is not surprising in view of the polar char-
acter ofthe DAB molecule, and explains most probably that
the concentration (5.5 mM) required for obtaining a large
density shift is 10-fold the optimal concentration of the assay
for free HRP (16).
Validity of the Method
In our hands, the DAB-induced density shift appeared as a
fairly simple, reproducible, and specific procedure. The spec-
ificity ofthe density shiftto ligand-HRP containing structures
was demonstrated by in vitro mixing experiments, a criterion
already used by Leskes et al. (19). In addition, only a minor
portion of the protein shifted after cytochemistry, and the
distribution of several marker enzymes present in the initial
preparation was largely unaffected (24).
However, the specificity of the procedure can be jeopard-
ized. The preparation should be virtually free of soluble, and
possibly externally exposed or adsorbed, HRP activity. As
mentioned in Results, free HRP rapidly oxidizedDAB outside
the organelles, leading to agglutination of the preparation.
This is an important caveat, since it may preclude the use of
the method in preparations containing soluble HRP or soluble
HRP conjugates. In addition, the possibility of obtaining a
specific density shift when HRP is associated to open struc-
tures, such as membrane fragments, is not yet documented.
Furthermore, subcellular fractions of different purity, com-
position, or origin may exhibit specific agglutinating proper-
ties or contain various amounts ofendogenous H202 or HRP
activity. As a consequence, it should be stressed that while a
dissociation in the distributions of different markers demon-
strated by the DAB shift procedure may be considered as
conclusive, the evidence ofthe association oftwo components
based on the criterion of concomitant DAB-induced density
shift requires that agglutination can be excluded, for example
by in vitro mixing experiments.
Analytical and Preparative Applications to
Subcellular Organelles
Most purification procedures based on specific density al-
terations induce a primary change in the density of specific
organelles, resulting from the in vivo accumulation of light
(11, 35, 36) or heavy material (15). In contrast, the density
alteration described in this and other (8, 19, 25) papers is
performed in vitro on subcellular organelles whose equilib-
rium density is initially unaffected.
Since DAB cytochemistry induces a shift towards heavier
densities, this procedure is particularly suited for the purifi-
cation of organelles equilibrating at a low density. Indeed, a
two-step purification protocol can be followed in this case. A
first density equilibration can be used to clear the preparation
from organelles equilibrating in the heavy region of the gra-
dient. After DAB cytochemistry is performed on the particles
equilibrating at low density, a second isopycnic centrifugation
will place HRP-containing particles at their new (heavier)
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ô75equilibrium density, in a region of the gradient devoid of
other particles. Particles without HRP will remain at their
initial density. Application of this strategy to the purification
of the low density ligand-containing structures is reported in
the companion paper(24).
Examination of the results reported here shows that the
shifted distributions of HRP-containing structures are more
disperse than the initial ones. This may affect the yield of a
purification. Assuming a Poisson distribution for the exoge-
nous marker molecules throughout a population of vesicles,
considerable variation may occur in the marker content of
individual vesicles, if the average number of molecules per
vesicle is small. For example, ifan average of 10 molecules of
HRP-conjugate have been introduced per low density vesicle,
the standard deviation will be 3.2 molecules per vesicle. Such
variation in the content of "active" ligand may account for
the observed dispersion in the distribution of ga1BSA-HRP-
containing vesicles, after DAB cytochemistry.
Our procedure can also be applied for analytical purposes,
in the same way as density shifts induced by other compounds,
such as digitonin or pyrophosphate (1). In the companion
paper, we report the application of DAB-induced density shift
to the analysis of highly purified ligand-containing structures,
using gaIBSA-HRP (24). The same procedure was also appli-
cable to the study of the lysosomal membrane of fibroblasts
after HRP uptake by fluid-phase endocytosis and accumula-
tion in lysosomes (10). Finally, we have also applied the
procedure of the DAB-induced density shift to the study of
ligand sorting in rat hepatocytes. Polymeric immunoglobulin
A, a ligand that is transferred into bile and ga1BSA-HRP,
which is digested in lysosomes, were injected simultaneously
at various times before sacrifice. The concomitant shift of
polymeric immunoglobulin A ("passive" ligand) and ga1BSA-
HRP ("active" ligand) was used to assess their association to
the same structure (6).
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